Labcorp Holdings Inc
LH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$398.00 | Wgcssp | Vwyxkchtt |
LabCorp Can Prioritize Diagnostics Now Without Distractions
Business Strategy and Outlook
As a leading independent diagnostic laboratory, LabCorp participates in a highly attractive duopoly that offers favorable prospects as healthcare moves toward reformed payment models, Medicare headwinds are again delayed, and potentially positive M&A opportunities rise.